BANK VONTOBEL/PUT/WALGREENS BOOTS ALLIANCE/27/0.1/21.06.24 Share Price

Warrant

DE000VU9JL48

Delayed Deutsche Boerse AG 09:22:05 23/05/2024 BST
0.97 EUR +1.04% Intraday chart for BANK VONTOBEL/PUT/WALGREENS BOOTS ALLIANCE/27/0.1/21.06.24
Current month+9.09%
1 month+15.66%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
23/05/24 0.97 +1.04%
22/05/24 0.96 +2.13%
21/05/24 0.94 +13.25%
20/05/24 0.83 0.00%
17/05/24 0.83 0.00%

Delayed Quote Deutsche Boerse AG

Last update May 23, 2024 at 09:22 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying WALGREENS BOOTS ALLIANCE, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VU9JL4
ISINDE000VU9JL48
Date issued 05/07/2023
Strike 27 $
Maturity 21/06/2024 (30 Days)
Parity 10 : 1
Emission price 0.24
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.97
Lowest since issue 0.18
Spread 0.01
Spread %1.02%

Company Profile

Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
Sector
-
More about the company

Ratings for Walgreens Boots Alliance, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Walgreens Boots Alliance, Inc.

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
16.47 USD
Average target price
22.77 USD
Spread / Average Target
+38.26%
Consensus